[
    "{\"step_by_step_thinking\": \"The documents provide a lot of information about the efficacy of galcanezumab in treating migraines. For instance, Document [0] states that galcanezumab resulted in a greater overall mean reduction in the number of monthly migraine headache days. Document [1] and Document [2] also mention that the benefit of galcanezumab was assessed based on the change from baseline in the number of migraine days per month. Document [3] mentions that galcanezumab is superior to placebo in reducing migraine headaches. Document [4] concludes that galcanezumab is a safe and effective treatment for adult patients with episodic and chronic migraine. All these documents suggest that galcanezumab is effective in treating migraines.\", \"answer_choice\": \"A\"}"
]